Home > Products Pipeline > Methylene Blue MMX


LuMeBlue™ is a novel application of methylene blue, a vital dye that is used to stain the mucosa and identify pre-cancerous lesions and polyps in the colon during endoscopy. The objective is to deliver methylene blue along the length of the entire colon via an oral tablet formulation of the MMX delayed release technology thus enabling endoscopists to better detect pre-cancerous and cancerous lesions and polyps throughout the entire colon.
The Company has completed 3 Phase II trials and successfully just completed multicenter Phase III clinical trials in the US and Europe for treatment of patients undergoing routine colonoscopy. The primary objective of this trial was to achieve superiority in the proportion of subjects in which histologically proven Adenoma or Carcinoma is detected using LuMeBlue™ versus white light endoscopy.

  • LuMeBlue™